Complete Genomics Inc (GNOM) Annual Balance Sheets

Annual · GAAP · USD millions
Access GNOM quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Complete Genomics Inc balances growth, leverage, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2011)
Assets
Cash & cash equivalent77.07
Short-term Investments, Total6.00
Cash & Short-term Investments83.00
Accounts receivable6.49
Inventories4.12
Other Current Assets0.34
Prepaid Expense, Current AS1.14
Total Current Assets95.17
Equipment/Property/Plant Net33.59
Other Assets, Noncurrent1.45
Total Assets130.20
Liabilities
Accounts Payable, Current AC5.36
Accrued Liabilities, Current AC5.40
Notes Payable, Current NO7.10
Deferred Revenue, Current DE10.03
Total Current Liabilities27.89
Long-term debt16.16
Total Long-term Debt16.16
Deferred Rent Credit, Noncurrent DE3.54
Total Liabilities47.59
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock293.78
Retained Earnings / Accumulated Deficit-211.20
Other Equity0.00
Common Stockholder's Equity82.61
Total Stockholder's Equity82.61
Liabilities & Stockholder's Equity130.20
4 historic quarters locked

Sign in to unlock the full Complete Genomics Inc balance sheet history.

About GNOM Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License